Skip to main content

Applied Biosystems, Eurogentec Ink Probe Manufacturing Pact

NEW YORK (GenomeWeb News) – Belgian reagents manufacturer Eurogentec today said that it has licensed from Life Technologies business Applied Biosystems the rights to manufacture and sell dual-labeled oligonucleotide probes worldwide for use in the 5' nuclease process.

The agreement was signed under AB's Probe Manufacturing License Program and provides Eurogentec with limited pass-through use rights to its research customers. It also provides Eurogentec with rights under several probe composition and method patents to offer oligo design services for probes and primers for use in real-time PCR.

The agreement "confirms the validity of our previous investments in PCR and real-time PCR," Eurogentec CSO Philippe Cronet said in a statement. "In addition to the benefits for the research market, the new agreement is an important cornerstone in our on-going commitment to serve the commercial molecular diagnostic assay market."

Financial terms of the agreement were not disclosed.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.